Empery Asset Management, LP 13F holdings, Q1 2026
Holdings as of March 31, 2026 · filings on SEC EDGAR · latest filing →
Empery Asset Management, LP disclosed 32 US equity positions worth $83.0m in its Q1 2026 13F filing. The largest position was XFOR at 44.5% of the reported book, followed by EMPERY DIGITAL INC and DTIL.
What did Empery Asset Management, LP own in Q1 2026? Top 32 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | XFOR X4 PHARMACEUTICALS INC | 44.5% | $36.9m | 8,944,118 | – | ||
| 2 | EMPERY DIGITAL INC | 14.9% | $12.4m | 2,930,345 | – | ||
| 3 | DTIL PRECISION BIOSCIENCES INC | 13.0% | $10.8m | 1,968,879 | – | ||
| 4 | IMPERIAL PETE INC | 4.5% | $3.8m | 877,645 | – | ||
| 5 | VENU VENU HLDG CORP | 4.0% | $3.3m | 1,007,729 | – | ||
| 6 | TNYA TENAYA THERAPEUTICS INC | 3.6% | $3.0m | 4,286,933 | – | ||
| 7 | BSIN U S ENERGY CORP DEL | 2.0% | $1.7m | 1,917,844 | – | ||
| 8 | SCYX SCYNEXIS INC | 2.0% | $1.7m | 1,847,826 | – | ||
| 9 | CYNGN INC | 1.9% | $1.6m | 957,784 | – | ||
| 10 | JAGUAR URANIUM CORP | 1.6% | $1.3m | 487,500 | – | ||
| 11 | MSLE SATELLOS BIOSCIENCE INC | 1.6% | $1.3m | 230,100 | – | ||
| 12 | CRITICAL METALS CORP | 1.3% | $1.0m | 132,039 | – | ||
| 13 | URG UR-ENERGY INC | 1.1% | $924.0k | 620,136 | – | ||
| 14 | PROMIS NEUROSCIENCES INC | 0.9% | $766.5k | 60,353 | – | ||
| 15 | SUPER LEAGUE ENTERPRISE INC | 0.6% | $491.8k | 132,917 | – | ||
| 16 | TLPH TALPHERA INC | 0.5% | $441.0k | 590,481 | – | ||
| 17 | BENITEC BIOPHARMA INC | 0.4% | $324.2k | 30,440 | – | ||
| 18 | BRIACELL THERAPEUTICS CORP | 0.4% | $309.0k | 300,000 | – | ||
| 19 | ABITS GROUP INC | 0.3% | $266.1k | 172,761 | – | ||
| 20 | PRZO PARAZERO TECHNOLOGIES LTD | 0.3% | $217.6k | 282,199 | – | ||
| 21 | NSRX NASUS PHARMA LTD | 0.1% | $101.7k | 45,803 | – | ||
| 22 | BRIACELL THERAPEUTICS CORP | 0.1% | $93.3k | 666,600 | – | ||
| 23 | NUTRIBAND INC | 0.1% | $45.0k | 40,218 | – | ||
| 24 | MARIS TECH LTD | 0.1% | $44.9k | 297,600 | – | ||
| 25 | RENATUS TACTICAL ACQUIS | 0.0% | $23.0k | 50,000 | – | ||
| 26 | NEUROSENSE THERAPEUTICS LTD | 0.0% | $20.1k | 100,402 | – | ||
| 27 | SPECTRAL AI INC | 0.0% | $18.7k | 33,336 | – | ||
| 28 | CEA INDUSTRIES INC | 0.0% | $15.3k | 500,000 | – | ||
| 29 | MEDICUS PHARMA LTD | 0.0% | $11.5k | 12,100 | – | ||
| 30 | NEXERA TECHNOLOGIES LTD | 0.0% | $6.1k | 360,577 | – | ||
| 31 | NEXGEL INC | 0.0% | $5.4k | 90,000 | – | ||
| 32 | FGI INDUSTRIES LTD | 0.0% | $2.7k | 83,928 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.